A clinical trial involving glucagon was updated on October 9, 2026. The trial, registered as NCT07868601 and titled "LIfestyle MEtabotype Study A," is currently listed with a status of recruiting.
No phase information was provided for this trial in the available record. The listing does not include results, efficacy data, or safety findings at this time.
Glucagon is an approved compound, and this trial update reflects only its recruitment status within the registered study. Readers should note that recruiting status indicates the trial is open for participant enrollment, not that any outcomes have been determined or reported.
Further details about the study design, eligibility, and objectives can be found through the official trial registry listing. As the trial progresses, additional updates regarding status changes or results may become available through ClinicalTrials.gov.
For more background on glucagon, including its approved uses and general pharmacological context, readers can consult the compound overview.